THE FEMINIZING SYNDROME IN MALE SUBJECTS WITH ADRENOCORTICAL NEOPLASMS.
D015068:17-Ketosteroids; D000310:Adrenal Gland Neoplasms; D047808:Adrenogenital Syndrome; D004958:Estradiol; D004964:Estriol; D004967:Estrogens; D004970:Estrone; D005640:Follicle Stimulating Hormone; D006177:Gynecomastia; D006801:Humans; D007006:Hypogonadism; D008297:Male; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000532:radiotherapy*; D011276:Pregnanediol; D013514:Surgical Procedures, Operative; D013737:Testis; D014556:Urine
D015068:17-Ketosteroids; D004967:Estrogens; D004970:Estrone; D004958:Estradiol; D005640:Follicle Stimulating Hormone; D004964:Estriol; D011276:Pregnanediol
17-KETOSTEROIDS; ADRENAL GLAND NEOPLASMS; ADRENOGENITAL SYNDROME; ESTRADIOL; ESTRIOL; ESTROGENS; ESTRONE; FSH; GYNECOMASTIA; HYPOGONADISM; NEOPLASM METASTASIS; NEOPLASM RADIOTHERAPY; PREGNANEDIOL; SURGERY, OPERATIVE; TESTIS; URINE